Fortress Biotech, Inc.
Fortress Biotech, Inc. (FBIO) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
fbio · stock forecast · 6 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 6 Wall Street analysts in the past 3 months
Buy
6 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$5.00
Consensus
$5.00
+75.4% upside
Low
$5.00
Median: $5 · Last Close: $2.85
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $2.94 | ↑ 3.00% |
1-day model range: $2.91–$2.96. Peak: $2.96 (+3.00%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $3 | -4.2% |
| 2028 | $3 | -6.2% |
| 2029 | $3 | -7.2% |
| 2030 | $3 | -7.6% |
| 2031 | — | -7.9% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · FBIO · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-02-23 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-08-21 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-11 | Roth MKM | Maintains | Buy→Buy |
| 2024-11-18 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-07-19 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-05-16 | Roth MKM | Maintains | Buy→Buy |
| 2023-11-29 | Roth MKM | Maintains | Buy→Buy |
| 2023-08-15 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2023-08-14 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2023-05-16 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Fortress Biotech, Inc. (FBIO) stock. Of the recent 21 rating actions, 0 were upgrades and 0 were downgrades. 6 analysts currently cover FBIO.
Analyst Recommendation Trends
FBIO analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$85M
↑ 16.1% YoY
Revenue Next Year
$57M
↓ 32.9% YoY
EPS This Year
$-5.87
EPS Next Year
$-3.51
↓ 40.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast FBIO EPS of $-5.87 for the current fiscal year, based on estimates from 1 analysts. The FBIO revenue forecast is $85M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The FBIO stock forecast is supported by two independent data sources: analyst consensus ratings from 6 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus FBIO price target is $5.00 (+75.4% upside), with an analyst consensus of Buy.
The FBIO short-term stock prediction for tomorrow is $2.94 (+3.00%). The FBIO stock price prediction for 2027 estimates an average of $3. The FBIO stock prediction for 2030 projects a range of $2–$3.
Fortress Biotech, Inc. trades on NASDAQ under the ticker FBIO. The FBIO stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
FBIO forecast · 8 questionsAccording to 6 Wall Street analysts, the average 12-month FBIO price target is $5.00, with a high forecast of $5.00 and a low of $5.00. The median price target is shown in the chart above when available. This implies +75.4% potential upside from the current price of $2.85.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.